Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523794 · ClinicalTrials.gov registry record · NA
Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis
A NA study, sponsored by Revalesio Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02523794: Clinical Trial NA study, sponsored by Revalesio Corporation.
NCT02523794 is a NA study that was terminated before completion, run by Revalesio Corporation. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02523794, a NA study, was terminated before completion, sponsored by Revalesio Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of electro-kinetically modified water (EMW) beverage, consumed twice daily (BID) for 3 months in the management of endometriosis associated pain, and to evaluate the effect of EMW consumption on analgesic use for endometriosis associated pain.
Interventions
- OTHER Placebo
- OTHER Electro-kinetically Modified Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-09 |
| Phase | NA |
Why NCT02523794 stopped before completion
NCT02523794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02523794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02523794 about?
NCT02523794 is a clinical study titled "Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis". The purpose of this study is to evaluate the efficacy of electro-kinetically modified water (EMW) beverage, consumed twice daily (BID) for 3 months in the management of endometriosis associated pain, and to evaluate the effect of EMW consumption on analgesic use for endometriosis associated pain.
What is the current status of trial NCT02523794?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2015-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02523794?
The interventions under investigation include: Placebo (OTHER), Electro-kinetically Modified Water (OTHER).
Who is sponsoring clinical trial NCT02523794?
This trial is sponsored by Revalesio Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02523794's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia